These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6647490)
1. Methods for the analysis of time to failure data. Prentice RL Prog Clin Biol Res; 1983; 132E():69-79. PubMed ID: 6647490 [No Abstract] [Full Text] [Related]
2. Proceedings of the Symposium on Designs for Clinical Cancer Research. Perspective of the clinician. Hoogstraten B Cancer Treat Rep; 1980; 64(2-3):537-8. PubMed ID: 7407796 [No Abstract] [Full Text] [Related]
3. Proceedings of the Symposium on Designs for Clinical Cancer Reseach. Discussion I: Basic design considerations. Cancer Treat Rep; 1980; 64(2-3):411-7. PubMed ID: 7407778 [No Abstract] [Full Text] [Related]
4. Sequential clinical trials in cancer research. George SL Cancer Treat Rep; 1980; 64(2-3):393-7. PubMed ID: 7407775 [TBL] [Abstract][Full Text] [Related]
6. Clinical trials in psychosocial medicine: methodologic and statistical considerations. Part I. Introduction. Schmale AH Cancer Treat Rep; 1980; 64(2-3):441-3. PubMed ID: 7407782 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of toxicity: statistical considerations. Herson J Cancer Treat Rep; 1980; 64(2-3):463-8. PubMed ID: 7407785 [TBL] [Abstract][Full Text] [Related]
8. Designing for cancer clinical trials: selection of prognostic factors. Brown BW Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790 [TBL] [Abstract][Full Text] [Related]
9. Data analysis I. Some statistical tests for small related samples. Pethybridge RJ J R Nav Med Serv; 1980; 66(2):135-9. PubMed ID: 7431255 [No Abstract] [Full Text] [Related]
10. [Problems raised by interim analysis in therapeutic trials]. Rodary C; Nougue CC Bull Cancer; 1982; 69(4):387-92. PubMed ID: 7150794 [TBL] [Abstract][Full Text] [Related]
11. Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables. Anderson JR; Cain KC; Gelber RD J Clin Oncol; 2008 Aug; 26(24):3913-5. PubMed ID: 18711176 [No Abstract] [Full Text] [Related]
12. [From empiricism to therapeutic trials. Or how statistical methods can contribute to the improvement of therapeutic protocols in cervicofacial oncology]. Cachin Y; Flamant R; Richard J; Sancho-Garnier H Ann Otolaryngol Chir Cervicofac; 1982; 99(1-2):47-52. PubMed ID: 7103330 [No Abstract] [Full Text] [Related]
13. Clinical trials: what you and your patients need to know. Yoder LH Medsurg Nurs; 2005 Oct; 14(5):351-3; quiz 354. PubMed ID: 16318119 [No Abstract] [Full Text] [Related]
14. Design and analysis of prostate cancer trials. Sylvester R Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926 [TBL] [Abstract][Full Text] [Related]
15. Five easy pieces on evidence-based medicine (4). Kalso E; Edwards J; McQuay HJ; Moore RA Eur J Pain; 2002; 6(1):89-93. PubMed ID: 11888232 [No Abstract] [Full Text] [Related]
19. Patient heterogeneity in clinical trials. Simon R Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777 [TBL] [Abstract][Full Text] [Related]
20. Clinical trials in psychosocial medicine: methodologic and statistical considerations. Part III. Assessing measurement techniques in psychosocial oncology. Morrow GR Cancer Treat Rep; 1980; 64(2-3):451-6. PubMed ID: 7407784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]